Long-term infliximab for severe hidradenitis suppurativa [21]

British Journal of Dermatology

Volumn 155, Issue 5, 2006, Pages 1105-1107

  Thielen, A M ^a   Barde, C ^a   Saurat, J H ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CLINDAMYCIN; CORTICOSTEROID; CYPROTERONE ACETATE; ETRETINATE; FINASTERIDE; INFLIXIMAB; ISOTRETINOIN; METHOTREXATE; RETINOID DERIVATIVE; RIFAMPICIN; TETRACYCLINE DERIVATIVE; TRIAMCINOLONE ACETONIDE; VALACICLOVIR;

ADULT; APOCRINE GLAND; CASE REPORT; DRUG EFFICACY; ERYTHEMA; HERPES ZOSTER; HUMAN; INFLAMMATION; LETTER; LONG TERM CARE; MAINTENANCE THERAPY; MALE; PERINEUM; PRIORITY JOURNAL; SKIN NODULE; SUPPURATIVE HIDRADENITIS; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTIBODIES, MONOCLONAL; ANUS DISEASES; DERMATOLOGIC AGENTS; HIDRADENITIS SUPPURATIVA; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 33749871789     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07528.x     Document Type: Letter

References (12)

1. Wiseman MC. Hidradenitis suppurativa: a review. Dermatol Ther 2004; 17:50-4.
2. Mendonca CO, Griffiths CE. Clindamycin and rifampicin combination therapy for hidradenitis suppurativa. Br J Dermatol 2006; 154:977-8.
3. Martinez F, Nos P, Benlloch S, Ponce J. Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab. Inflam Bowel Dis 2001; 7:323-6.
4. Katsanos KH, Christodoulou DK, Tsianos EV. Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn's disease patient. Am J Gastroenterol 2002; 97:2155-6.
5. Lebwohl B, Sapadin AN. Infliximab for the treatment of hidradenitis suppurativa. J Am Acad Dermatol 2003; 49:S275-6.
6. Sullivan TP, Welsh E, Kerdel FA et al. Infliximab for hidradenitis suppurativa. Br J Dermatol 2003; 149:1046-9.
7. Adams DR, Gordon KB, Devenyi AG, Ioffreda MD. Severe hidradrenitis suppurativa treated with infliximab infusion. Arch Dermatol 2003; 139:1540-2.
8. Cusack C, Buckley C. Etanercept: effective in the management of hidradenitis suppurativa. Br J Dermatol 2006; 154:726-9.
9. Miele E, Markowitz JE, Mamula P, Baldassano RN. Human antichimeric antibody in children and young adults with inflammatory bowel disease receiving infliximab. J Pediatr Gastroenterol Nutr 2004; 38:502-8.
10. Berger A, Edelsberg J, Li TT et al. Dose intensification with infliximab in patients with rheumatoid arthritis. Ann Pharmacother 2005; 39:2021-5.
11. Finckh A, Simard JF, Gabay C, Guerne PA, SCQM physicians Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis. Ann Rheum Dis 2006; 65:746-52.
12. Thielen AM, Kuenzli S, Saurat JH. Cutaneous adverse events of biological therapy for psoriasis: review of the literature. Dermatology 2005; 211:209-17.